What is your preferred dose and fractionation schedule for a patient with a stage III non-small cell lung cancer, whose comorbidities preclude chemotherapy, but has good enough performance status to warrant an attempt at longer-term local control?
What dose is preferred for central stage III NSCLC without chemotherapy? Do you recommend higher dose hypofractionated RT or conventional RT?